Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
NORWEST VENTURE PARTNERS XIV, LP (CIK 1842721) reported $60.4M across 2 reported positions in its SEC 13F filing for 2021-09-30. Largest positions: IMPL ($37.5M, 62.06%), OPEN ($22.9M, 37.94%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | IMPL | Impel NeuroPharma, Inc. | $37.5M | 62.06% | 3.1M | Hold |
| 2 | OPEN | Opendoor Technologies, Inc. | $22.9M | 37.94% | 1.1M | Trimmed |
Source: SEC Form 13F filings · as of 2021-09-30